"Antihypertensive Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.
Descriptor ID |
D000959
|
MeSH Number(s) |
D27.505.954.411.162
|
Concept/Terms |
Antihypertensive Agents- Antihypertensive Agents
- Agents, Antihypertensive
- Antihypertensives
- Anti-Hypertensives
- Anti Hypertensives
- Antihypertensive Drugs
- Drugs, Antihypertensive
- Anti-Hypertensive Agents
- Agents, Anti-Hypertensive
- Anti Hypertensive Agents
- Anti-Hypertensive Drugs
- Anti Hypertensive Drugs
- Drugs, Anti-Hypertensive
|
Below are MeSH descriptors whose meaning is more general than "Antihypertensive Agents".
Below are MeSH descriptors whose meaning is more specific than "Antihypertensive Agents".
This graph shows the total number of publications written about "Antihypertensive Agents" by people in this website by year, and whether "Antihypertensive Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 1 | 2 |
1996 | 1 | 2 | 3 |
1997 | 1 | 0 | 1 |
1998 | 1 | 1 | 2 |
1999 | 1 | 1 | 2 |
2000 | 2 | 1 | 3 |
2001 | 2 | 1 | 3 |
2002 | 4 | 0 | 4 |
2003 | 0 | 2 | 2 |
2004 | 1 | 2 | 3 |
2005 | 4 | 1 | 5 |
2006 | 3 | 1 | 4 |
2007 | 3 | 1 | 4 |
2008 | 4 | 0 | 4 |
2009 | 6 | 4 | 10 |
2010 | 5 | 8 | 13 |
2011 | 5 | 8 | 13 |
2012 | 6 | 5 | 11 |
2013 | 8 | 4 | 12 |
2014 | 5 | 2 | 7 |
2015 | 5 | 1 | 6 |
2016 | 5 | 4 | 9 |
2017 | 4 | 5 | 9 |
2018 | 9 | 6 | 15 |
2019 | 8 | 4 | 12 |
2020 | 4 | 5 | 9 |
2021 | 9 | 4 | 13 |
2022 | 0 | 10 | 10 |
2023 | 1 | 2 | 3 |
2024 | 4 | 5 | 9 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antihypertensive Agents" by people in Profiles.
-
Open-angle glaucoma and Fuchs dystrophy. J Cataract Refract Surg. 2024 Jul 01; 50(7):777.
-
Mean Arterial Pressure and Neonatal Outcomes in Pregnancies Complicated by Mild Chronic Hypertension. Obstet Gynecol. 2024 Jul 01; 144(1):101-108.
-
Pregnancy Outcomes of Nifedipine Compared With Labetalol for Oral Treatment of Mild Chronic Hypertension. Obstet Gynecol. 2024 Jul 01; 144(1):126-134.
-
Real-World Impact of Blood Pressure Control in Patients With Apparent Treatment-Resistant or Difficult-to-Control Hypertension and Stages 3 and 4 Chronic Kidney Disease. Am J Hypertens. 2024 May 15; 37(6):438-446.
-
Discharge medication delivery location and postpartum blood pressure control in patients with hypertensive disorders of pregnancy. Pregnancy Hypertens. 2024 Jun; 36:101125.
-
Prediction of cardiovascular and renal risk among patients with apparent treatment-resistant hypertension in the United States using machine learning methods. J Clin Hypertens (Greenwich). 2024 May; 26(5):500-513.
-
Age and Comorbidities Are Associated With Therapeutic Inertia Among Older Adults With Uncontrolled Blood Pressure. Am J Hypertens. 2024 Mar 15; 37(4):280-289.
-
RNA Interference With Zilebesiran for Mild to Moderate Hypertension: The KARDIA-1 Randomized Clinical Trial. JAMA. 2024 03 05; 331(9):740-749.
-
Circulating microRNA Biomarkers of Thiazide Response in Hypertension. J Am Heart Assoc. 2024 Feb 20; 13(4):e032433.
-
Association Between Hematoma Volume and Risk of Subsequent Ischemic Stroke: A MISTIE III and ATACH-2 Analysis. Stroke. 2024 Mar; 55(3):541-547.